The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...
CERo Therapeutics (CERO) announces that the U.S. Food and Drug Administration has cleared the Company’s Investigational New Drug ...
President-elect Donald Trump’s nominee would oversee agencies that regulate food, vaccines and medicine and were instrumental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback